|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.445 HKD | +1.14% |
|
+39.06% | -55.05% |
CANbridge Pharmaceuticals Inc. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 43.05 million compared to CNY 34.73 million a year ago. Net loss was CNY 218.16 million compared to CNY 249.01 million a year ago.
Basic loss per share from continuing operations was CNY 0.51 compared to CNY 0.59 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -55.05% | 24.15M | |
| +5.31% | 70.44B | |
| +10.97% | 8.94B | |
| -16.83% | 4.75B | |
| +43.48% | 4.5B | |
| +3.20% | 3.85B | |
| +18.82% | 2.38B | |
| -21.36% | 2.34B | |
| -29.67% | 2.2B | |
| +8.38% | 1.96B |
CANBRIDGE PHARMACEUTICALS INC. 
